Font Size: a A A

AIER Ophthalmology's Performance Impact Based On The "PE+ Listed Companies" Model

Posted on:2020-05-15Degree:MasterType:Thesis
Country:ChinaCandidate:Y B LiFull Text:PDF
GTID:2439330578960511Subject:Accounting
Abstract/Summary:PDF Full Text Request
At present,most listed companies in China are facing problems of slowing growth,industrial transformation,and technological changes.Because many industries are not concentrated enough,they need the industry leaders to integrate through mergers and acquisitions in order to enhance the control of listed companies on extended industry chains,and maintain the stable development of the company.The M&A and restructuring market has returned to active.In recent years,when AIER Ophthalmology expanded its epitaxial growth mode through M&A,it chose the industrial M&A fund of "PE+ listed company" mode.However,How is the specific effects,and what problems have arisen in the development of industrial funds?Can AIER avoid the relevant risk points?This is the main content of this paper.This paper first summarizes the domestic and foreign literary works on the "PE + listed company" model of industrial M&A funds,and then discriminates the related concepts,based on the M&A efficiency theory and synergy theory,and summarizes the meaning of performance impact of the listed companies-in this model;once again,the motivation and operation mode of the fund established by AIER Ophthalmology Group were sorted out;finally,the performance of AIER Ophthalmology was carried out by means of event research method,financial index analysis method and non-financial index analysis method.Then draws relevant conclusionsThe research results of this paper show that since 2014,AIER Ophthalmology has begun to combine endogenous development mode and epitaxial M&A strategy,and improved its own industrial chain with the help of "PE+ listed company" model fund.Performance display of the establishment of the industrial M&A funds shows that the short-term effect of the initial period of the industrial fund is relatively significant.As the time passed by and the integration of M&A industry chain,the market effect is gradually weakened.Under this model,the quality of the secondary merger has made outstanding contributions,effectively improved the company's overall bargaining level,enhanced the company's profitability,and the total assets increased rapidly,forming a "horizontal and vertical" layout,and the degree of resource sharing increased rapidly;With the professional investment team and financing channels of PE institutions,AIER Ophthalmology only need to investigate a small amount of capital to lever the capital leverage,gained capital advantage,and achieved synergy through the management of the investment target and resource integration,branching the hospital,extending network layout.However,in this process,a series of problems have emerged.This is because with the continuous progress of M&A activities,the scale of the enterprise has expanded rapidly,the capital chain and supply chain have been extended,and the progress of the integration planning of the entire industry chain has not kept the pace.The overall development speed of the group,therefore,this paper puts forward relevant suggestions at the end of the article,hoping to provide some reference for enterprises that want to stretch industrial chain extension through industrial M&A funds and implement diversified business development.
Keywords/Search Tags:"PE+ Listed Companies", AIER Ophthalmology, short-term effect, Business Performance, principal-agent issue, synergistic effect
PDF Full Text Request
Related items